Which pharmaceutical companies face the most patent expirations this year?
This infographic from DrugPatentWatch shows that Sanofi Aventis Us, Merck, Glaxosmithkline, Abbvie, Abraxis Bioscience, Genzyme, Abbott Endocrine,Boehringer Ingelheim, Merck And Co Inc, and Vyteris face the most patent expirations this year. Perhaps not surprisingly, GlaxoSmithKline and Sanofi Aventis are also among the firms with the most drug patents.
For more infographics, see the DrugPatentWatch Pharmaceutical Innovation Infographics.
Do you have a response to this infographic? Respond in the comments section below.Click here for reuse options!
Copyright 2013 Biotechblog